Combined casein kinase II and MAPK signalling inhibition as a therapeutic strategy for metastatic colorectal cancer
- DOI
- 10.1186/s40164-026-00855-4
- Published
- 2026-11-05
- Container
- Experimental Hematology & Oncology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s40164-026-00855-4,
title = {Combined casein kinase II and MAPK signalling inhibition as a therapeutic strategy for metastatic colorectal cancer},
author = {Mattia Marinucci and Federico Donà and Gina F. Boot and Cinzia Esposito and Elenia Toccafondi and Daniela Liberati and Andrej Benjak and Lara Zaidi and Melania Lazzari and Giulia Milardi and Karolina Guja-Jarosz and Miriam Cieri and Huiche Feng and Mairene Coto-Llerena and Raoul A. Droeser and Savas D. Soysal and Otto Kollmar and Guido Torzilli and Antonino Spinelli and Luigi M. Terracciano and Charlotte K. Y. Ng and Salvatore Piscuoglio},
year = {2026},
journal = {Experimental Hematology \& Oncology},
doi = {10.1186/s40164-026-00855-4},
url = {https://doi.org/10.1186/s40164-026-00855-4}
}RIS
TY - JOUR TI - Combined casein kinase II and MAPK signalling inhibition as a therapeutic strategy for metastatic colorectal cancer AU - Mattia Marinucci AU - Federico Donà AU - Gina F. Boot AU - Cinzia Esposito AU - Elenia Toccafondi AU - Daniela Liberati AU - Andrej Benjak AU - Lara Zaidi AU - Melania Lazzari AU - Giulia Milardi AU - Karolina Guja-Jarosz AU - Miriam Cieri AU - Huiche Feng AU - Mairene Coto-Llerena AU - Raoul A. Droeser AU - Savas D. Soysal AU - Otto Kollmar AU - Guido Torzilli AU - Antonino Spinelli AU - Luigi M. Terracciano AU - Charlotte K. Y. Ng AU - Salvatore Piscuoglio PY - 2026 JO - Experimental Hematology & Oncology DO - 10.1186/s40164-026-00855-4 UR - https://doi.org/10.1186/s40164-026-00855-4 ER -
APA
Marinucci, M., Donà, F., Boot, G. F., Esposito, C., Toccafondi, E., Liberati, D., Benjak, A., Zaidi, L., Lazzari, M., Milardi, G., Guja-Jarosz, K., Cieri, M., Feng, H., Coto-Llerena, M., Droeser, R. A., Soysal, S. D., Kollmar, O., Torzilli, G., Spinelli, A., Terracciano, L. M., Ng, C. K. Y., & Piscuoglio, S. (2026). Combined casein kinase II and MAPK signalling inhibition as a therapeutic strategy for metastatic colorectal cancer. Experimental Hematology & Oncology. https://doi.org/10.1186/s40164-026-00855-4
Source records
- crossref · retrieved 2026-11-07T14:43:17.047Z